FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Joenja (leniolisib) - March 24, 2023
- Rezzayo (rezafungin) - March 22, 2023
- Zynyz (retifanlimab-dlwr) - March 22, 2023
- Daybue (trofinetide) - March 10, 2023
- Zavzpret (zavegepant) - March 09, 2023
- Skyclarys (omaveloxolone) - February 28, 2023
- Altuviiio (antihemophilic factor recombinant, Fc-VWF-XTEN fusion protein-ehtl) - February 22, 2023
- Austedo XR (deutetrabenazine) - February 17, 2023
- Filspari (sparsentan) - February 17, 2023
- Syfovre (pegcetacoplan) - February 17, 2023
- Lamzede (velmanase alfa-tycv) - February 16, 2023
- Jesduvroq (daprodustat) - February 01, 2023
- Jaypirca (pirtobrutinib) - January 27, 2023
- Orserdu (elacestrant) - January 27, 2023
- Brenzavvy (bexagliflozin) - January 20, 2023
- Rykindo (risperidone) - January 13, 2023
- Airsupra (albuterol and budesonide) - January 10, 2023
- Leqembi (lecanemab-irmb) - January 06, 2023
- Briumvi (ublituximab-xiiy) - December 28, 2022
- NexoBrid (anacaulase-bcdb) - December 28, 2022